2025年3月最新中科院分区数据已更新,欢迎查询使用。如果您对期刊系统有任何需求或者问题,欢迎
反馈给我们。近期推荐: | 热 SCI论文AI润色+人工QC服务 | 热 IF2.9,JCR Q2肿瘤学期刊征稿中 | 热 赛默飞基础学科研究有奖问卷 | 热 同行专家帮助选刊 |
![]() |
基本信息 | 登录收藏 | |||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字![]() | Thoracic Cancer THORAC CANCER (此期刊被最新的JCR期刊SCIE收录) LetPub评分 6.2
56人评分
我要评分
声誉 6.9 影响力 5.0 速度 9.2 | |||||||||||||||||||||||||||||||
期刊ISSN | 1759-7706 | 微信扫码收藏此期刊 | ||||||||||||||||||||||||||||||
E-ISSN | 1759-7714 | |||||||||||||||||||||||||||||||
2023-2024最新影响因子 (数据来源于搜索引擎) | 2.3 点击查看影响因子趋势图 | |||||||||||||||||||||||||||||||
实时影响因子 | 截止2025年5月19日:2.329 | |||||||||||||||||||||||||||||||
2023-2024自引率 | 4.30%点击查看自引率趋势图 | |||||||||||||||||||||||||||||||
五年影响因子 | 2.8 | |||||||||||||||||||||||||||||||
JCI期刊引文指标 | 0.61 | |||||||||||||||||||||||||||||||
h-index | 20 | |||||||||||||||||||||||||||||||
CiteScore ( 2024年最新版) |
| |||||||||||||||||||||||||||||||
期刊简介 |
| |||||||||||||||||||||||||||||||
期刊官方网站 | http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1759-7714 | |||||||||||||||||||||||||||||||
期刊投稿格式模板 VIP专享 |
| |||||||||||||||||||||||||||||||
期刊投稿网址 | https://mc.manuscriptcentral.com/tca | |||||||||||||||||||||||||||||||
期刊语言要求 | 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足Thoracic Cancer的语言要求,还能让Thoracic Cancer编辑和审稿人得到更好的审稿体验,让稿件最大限度地被Thoracic Cancer编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评(1篇) 论文致谢(6篇) 。
提交文稿 | |||||||||||||||||||||||||||||||
是否OA开放访问 | Yes | |||||||||||||||||||||||||||||||
OA期刊相关信息![]() | 文章处理费:需要( USD2750; GBP1850; EUR2500; ) 文章处理费豁免:查看说明 其他费用:没有 期刊主题关键词:treatment and research、asia-pacific、thoracic cancer、prevention 相关链接:Aims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review | |||||||||||||||||||||||||||||||
通讯方式 | 111 RIVER ST, HOBOKEN, USA, NJ, 07030-5774 | |||||||||||||||||||||||||||||||
出版商 | Blackwell Publishing Asia Pty Ltd | |||||||||||||||||||||||||||||||
涉及的研究方向 | ONCOLOGY-RESPIRATORY SYSTEM | |||||||||||||||||||||||||||||||
出版国家或地区 | PEOPLES R CHINA | |||||||||||||||||||||||||||||||
出版语言 | English | |||||||||||||||||||||||||||||||
出版周期 | ||||||||||||||||||||||||||||||||
出版年份 | 2010 | |||||||||||||||||||||||||||||||
年文章数 | 374点击查看年文章数趋势图 | |||||||||||||||||||||||||||||||
Gold OA文章占比 | 68.37% | |||||||||||||||||||||||||||||||
研究类文章占比: 文章 ÷(文章 + 综述) | 94.65% | |||||||||||||||||||||||||||||||
WOS期刊SCI分区 ( 2023-2024年最新版) | WOS分区等级:2区
| |||||||||||||||||||||||||||||||
中国科学院《国际期刊预警 名单(试行)》名单 | 2025年03月发布的2025版:不在预警名单中 2024年02月发布的2024版:不在预警名单中 2023年01月发布的2023版:不在预警名单中 2021年12月发布的2021版:不在预警名单中 2020年12月发布的2020版:不在预警名单中 | |||||||||||||||||||||||||||||||
中国科学院SCI期刊分区 ( 2025年3月最新升级版) | 点击查看中国科学院SCI期刊分区趋势图
| |||||||||||||||||||||||||||||||
中国科学院SCI期刊分区 ( 2023年12月升级版) |
| |||||||||||||||||||||||||||||||
中国科学院SCI期刊分区 ( 2022年12月旧的升级版) |
| |||||||||||||||||||||||||||||||
SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE) Scopus (CiteScore) Directory of Open Access Journals (DOAJ) | |||||||||||||||||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1759-7706%5BISSN%5D | |||||||||||||||||||||||||||||||
平均审稿速度 | 网友分享经验: 平均2月 | |||||||||||||||||||||||||||||||
平均录用比例 | 网友分享经验: 约75% | |||||||||||||||||||||||||||||||
版面费/APC文章处理费信息 | 文章处理费:需要( USD2750; GBP1850; EUR2500; ) 文章处理费豁免:查看说明 其他费用:没有 LetPub提供文章处理费(APC)支持服务,可以用人民币支付版面费啦! | |||||||||||||||||||||||||||||||
LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)后论文在Thoracic Cancer顺利发表。
快看看作者怎么说吧:服务好评(1篇) 论文致谢(6篇) 。 提交文稿 | |||||||||||||||||||||||||||||||
期刊常用信息链接 |
|
|
|
|
中国学者近期发表的论文 | |
1. | Comparison of Wedge Resection and Anatomical Lung Resection in Elderly Patients With Early-Stage Nonsmall Cell Lung Cancer With Visceral Pleural Invasion: A Population-Based Study Author: Li, Shuyuan; Ge, Yong; Ma, Ran; Wang, Jiayi; Ma, Tianyue; Sun, Teng; Feng, Shoujie; Zhang, Cheng; Zhang, Hao Journal: THORACIC CANCER. 2025; Vol. 16, Issue 3, pp. -. DOI: 10.1111/1759-7714.15532 PubMed DOI |
2. | Reassessment of the Prognostic Implication of Ground-Glass Opacity: An Investigation Into Hypermetabolic Clinical Stage IA Lung Adenocarcinoma Author: Li, Runze; Chen, Jianchuan; Li, Zhifei; Li, Peng; Qiu, Bin; Tan, Fengwei Journal: THORACIC CANCER. 2025; Vol. 16, Issue 3, pp. -. DOI: 10.1111/1759-7714.15530 PubMed DOI |
3. | Effects of Postoperative Complications on Overall Survival Following Esophagectomy: A Meta-Analysis Using the Restricted Mean Survival Time Analysis Author: Yang, Yongbo; Han, Chunyang; Xing, Xing; Qin, Zhen; Wang, Qianning; Lan, Lu; Zhu, He Journal: THORACIC CANCER. 2025; Vol. 16, Issue 3, pp. -. DOI: 10.1111/1759-7714.70011 PubMed DOI |
4. | A Multi-Center Real-World Study of Clinicopathologic Characteristics and Efficacy of the Malignant Mesothelioma in Chinese Population Author: Sun, Chenrui; Yang, Xue; Chen, Lan; Bie, Zhixin; Kang, Runting; Ai, Bin; Ma, Junling; Zheng, Zitong; Liu, Haolan; Liu, Juanjuan; Zhong, Jia; Yu, Jiangyong Journal: THORACIC CANCER. 2025; Vol. 16, Issue 3, pp. -. DOI: 10.1111/1759-7714.15533 PubMed DOI |
5. | An Observational Study Evaluating the Safety of Neoadjuvant Immunotherapy Combined With Chemotherapy in Patients Undergoing Surgery for Non-Small Cell Lung Cancer Author: Ye, Xin; Miao, Jinbai; Li, Hui; Hu, Bin Journal: THORACIC CANCER. 2025; Vol. 16, Issue 3, pp. -. DOI: 10.1111/1759-7714.70002 PubMed DOI |
6. | Exploring the Clinical Value of Perioperative ctDNA-Based Detection of Molecular Residual Disease in Patients With Esophageal Squamous Cell Carcinoma Author: Li, Jimin; Wu, Congcong; Song, Yongming; Fan, Yuhui; Li, Chao; Li, Haibo; Zhang, Shuangping Journal: THORACIC CANCER. 2025; Vol. 16, Issue 4, pp. -. DOI: 10.1111/1759-7714.70017 PubMed DOI |
7. | METTL3/IGF2BP2 Promotes the Malignant Progression of Esophageal Cancer by Activating the PIK3CA/AKT Pathway Author: Guo, Xinmeng; Huang, Anqi; Qi, Ya'nan; Chen, Jiaqi; Yang, Meng; Jin, Mulan Journal: THORACIC CANCER. 2025; Vol. 16, Issue 4, pp. -. DOI: 10.1111/1759-7714.70022 PubMed DOI |
8. | Perioperative Treatment in EGFR-Mutant Early-Stage Non-Small Cell Lung Cancer: Current Evidence and Future Perspectives Author: Guo, Xiaobei; Liu, Xiaoyan; Guo, Chao; Miao, Qian; Cheng, Xinghua; Hong, Xuan; Li, Hongru; Qiu, Xiaoming; Xiang, Yi; Zheng, Di; Zhou, Jian; Jiang, Liyan; Xu, Yan; Wang, Mengzhao Journal: THORACIC CANCER. 2025; Vol. 16, Issue 4, pp. -. DOI: 10.1111/1759-7714.70018 PubMed DOI |
9. | Optimizing Shoulder Joint Positioning During Video-Assisted Thoracoscopic Surgery: A Prospective Study on Prevention of Postoperative Ipsilateral Shoulder Pain Author: Zhao, Yan; Gu, Yang; Hu, Bin Journal: THORACIC CANCER. 2025; Vol. 16, Issue 2, pp. -. DOI: 10.1111/1759-7714.15528 PubMed DOI |
10. | Indocyanine Green Fluorescence Plus Blue Dye for Sentinel Lymph Node Biopsy in Patients Undergoing Neoadjuvant Chemotherapy for Breast Cancer: A Multicenter, Prospective Cohort Study Author: Liu, Miao; Yang, Yang; Hua, Bin; Feng, Rui; Xu, Tianyu; Wang, Mengyuan; Qi, Xiaowei; Cao, Yingming; Zhou, Bo; Tong, Fuzhong; Liu, Peng; Liu, Hongjun; Cheng, Lin; Yang, Houpu; Xie, Fei; Wang, Siyuan; Wang, Chaobin; Peng, Yuan; Shen, Danhua; Chen, Lei; Jiang, Jun; Wang, Shu Journal: THORACIC CANCER. 2025; Vol. 16, Issue 2, pp. -. DOI: 10.1111/1759-7714.15511 PubMed DOI |
|
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2025 中国: LetPub上海 网站备案号:沪ICP备10217908号-1 沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)
增值电信业务经营许可证:沪B2-20211595 网络文化经营许可证:沪网文[2023]2004-152号
礼翰商务信息咨询(上海)有限公司 办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室